AUPH

Aurinia Pharmaceuticals Inc

5.53 USD
-0.01 (-0.18%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Aurinia Pharmaceuticals Inc stock is down -4.33% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 10 June’s closed higher than May. In the last 5 Unusual Options Trades, there were 5 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
02 May 15:11 19 Jul, 2024 5.00 CALL 1451 560
02 May 15:20 19 Jul, 2024 5.00 CALL 1000 560
02 May 15:20 19 Jul, 2024 5.00 CALL 500 560
02 May 15:21 19 Jul, 2024 5.00 CALL 6950 560
22 May 14:51 16 Jan, 2026 3.00 CALL 100 135

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc. focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis.